Screening for Fabry Disease in patients with unexplained left ventricular hypertrophy-Reference-Cited by-同舟云学术

Screening for Fabry Disease in patients with unexplained left ventricular hypertrophy

Published:2020-09-28 Issue:9 Volume:15 Page:e0239675
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Sadasivan Chandu,Chow Josie T. Y.,Sheng Bun,Chan David K. H.,Fan Yiting,Choi Paul C. L.,Wong Jeffrey K. T.,Tong Mabel M. B.,Chan Tsz-Ngai,Fung Erik,Kam Kevin K. H.,Chan Joseph Y. S.,Chi Wai-Kin,Paterson D. Ian,Senaratne Manohara,Brass Neil,Oudit Gavin Y.^ORCID,Lee Alex P. W.

Funder

Sanofi Genzyme

Hong Kong Special Administrative Region Government Health and Medical Research Fund

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference49 articles.

1. Narrative Review: Fabry Disease;JTR Clarke;Annals of Internal Medicine,2007

2. The Molecular Defect Leading to Fabry Disease: Structure of Human α-Galactosidase;SC Garman;Journal of Molecular Biology,2004

3. Anderson-Fabry Disease: A Multiorgan Disease.;T Antonino;Current Pharmaceutical Design,2013

4. Clinical Features, Diagnosis, and Management of Patients With Anderson-Fabry Cardiomyopathy;H Yogasundaram;Can J Cardiol,2017

5. Anderson-Fabry cardiomyopathy: prevalence, pathophysiology, diagnosis and treatment;BN Putko;Heart Failure Reviews,2015

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Screening for Fabry disease in patients with left ventricular hypertrophy in China: A multicentre and prospective study;ESC Heart Failure;2024-09-03

2. The Asian Fabry Cardiomyopathy High-Risk Screening Study 2 (ASIAN-FAME-2): Prevalence of Fabry Disease in Patients with Left Ventricular Hypertrophy;Journal of Clinical Medicine;2024-07-02

3. Anderson–Fabry disease management: role of the cardiologist;European Heart Journal;2024-03-15

4. FDrisk: development of a validated risk assessment tool for Fabry disease utilizing electronic health record data;Journal of Rare Diseases;2024-01-04

5. Impact of GLA Variant Classification on the Estimated Prevalence of Fabry Disease: A Systematic Review and Meta-Analysis of Screening Studies;Circulation: Genomic and Precision Medicine;2023-12-04